Me-Too Drugs – Innovation Killers or Backbone of Drug Discovery?
‘Me-too’ or ‘follow-on’ drugs are the copycats of the drug discovery landscape. Taking inspiration from existing drugs and making small modifications to them, many new therapies have been developed in this manner. Despite their reputation for lacking novelty and innovation, the sheer success of me-too drugs, like the blockbuster drug Lipitor, makes them the backbone of many medicinal chemistry programs.
(more…)